Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy

NCT01553578 — Not applicable, Completed, 244 participants, Wake Forest University Health Sciences

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

The Efficacy of Healing Touch Versus Guided Imagery on Pain, Fatigue, Nausea, and Anxiety in Patients' Receiving Outpatient Chemotherapy

RegistryNCT01553578
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, supportive care
Enrollment244 (Actual)
SponsorWake Forest University Health Sciences (Other); collaborators: National Cancer Institute (NCI)
ConditionsAnxiety Disorder, Fatigue, Malignant Neoplasm, Nausea and Vomiting, Pain
Interventionsquestionnaire administration, therapeutic touch, management of therapy complications, standard follow-up care (Other, procedure, behavioral)
Datesstart 2012-02-01, primary completion 2013-02-01, completion 2013-02-01, first posted 2012-03-14, last updated 2018-07-05
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Anxiety Disorder All trials for Fatigue All trials of questionnaire administration All trials of therapeutic touch

-Summary

This randomized clinical trial studies healing touch or guided imagery in treating pain, fatigue, nausea, and anxiety in patients undergoing chemotherapy. Healing touch and guided imagery may help treat complications caused by chemotherapy. It is not yet known whether healing touch or guided imagery is more effective in treating pain, fatigue, nausea, and anxiety in patients undergoing chemotherapy

Expand all sections  ·  Collapse all

+Detailed description

PRIMARY OBJECTIVES:

I. To determine if the provision of healing touch or guided imagery during outpatient chemotherapy is associated with decreased pain, fatigue, nausea and anxiety when compared to standard outpatient treatment protocols.

OUTLINE: Patients are randomized to 1 of 3 treatment arms.

ARM A: Patients receive 30 minutes of healing touch therapy comprising magnetic clearing, pain drains, hands in motion/hands still and mind clearing.

ARM B: Patients listen to guided imagery audiotapes for 30 minutes

ARM C: Patients receive standard of care.

+Arms and interventions

ArmTypeInterventionsDescription
Arm A (healing touch therapy)ExperimentalOther: questionnaire administration; Procedure: therapeutic touch; Behavioral: management of therapy complicationsPatients receive 30 minutes of healing touch therapy consisting of magnetic clearing, pain drains, hands in motion/hands still and mind clearing.
Arm B (guided imagery)ExperimentalOther: questionnaire administration; Behavioral: management of therapy complicationsPatients listen to guided imagery audiotapes for 30 minutes.
Arm C (standard care)Active comparatorOther: questionnaire administration; Procedure: standard follow-up carePatients receive standard of care.
  • questionnaire administration (Other): Ancillary studies
  • therapeutic touch (Procedure), also known as healing touch: Receive healing touch therapy
  • management of therapy complications (Behavioral), also known as complications of therapy, management of: Receive healing touch therapy
  • management of therapy complications (Behavioral), also known as complications of therapy, management of: Receive guided imagery audiotapes
  • standard follow-up care (Procedure): Receive standard care

+Outcome measures

Primary outcomes

  • Change scores for each patient on pain scale [Approximately 6 months]: Collected using a 10 point visual analog scale for pain, fatigue, nausea, and anxiety. Analyzed initially using descriptive statistics. Compared among the 3 groups using one-way analysis of variance (ANOVA) models and 2-sample t-tests.
  • Change scores for each patient on fatigue scale [Approximately 6 months]: Collected using a 10 point visual analog scale for pain, fatigue, nausea, and anxiety. Analyzed initially using descriptive statistics. Compared among the 3 groups using one-way analysis of variance (ANOVA) models and 2-sample t-tests.
  • Change scores for each patient on nausea scale [Approximately 6 months]: Collected using a 10 point visual analog scale for pain, fatigue, nausea, and anxiety. Analyzed initially using descriptive statistics. Compared among the 3 groups using one-way analysis of variance (ANOVA) models and 2-sample t-tests.
  • Change scores for each patient on anxiety scale [Approximately 6 months]: Collected using a 10 point visual analog scale for pain, fatigue, nausea, and anxiety. Analyzed initially using descriptive statistics. Compared among the 3 groups using one-way analysis of variance (ANOVA) models and 2-sample t-tests.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Adult patients at the outpatient chemotherapy area will be enrolled without consideration for type of cancer or chemotherapeutic agents to be used

+Locations (1)

FacilityCityCountryStatus
Comprehensive Cancer Center of Wake Forest UniversityWinston-Salem, North CarolinaUnited States

+Investigators

  • Lisa Hodges, Principal investigator, Wake Forest University Health Sciences